These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32147131)

  • 21. Optic radiations are thinner and show signs of iron deposition in patients with long-standing remitting-relapsing multiple sclerosis: an enhanced T
    Zeng C; Du S; Han Y; Fu J; Luo Q; Xiang Y; Chen X; Luo T; Li Y; Zheng Y
    Eur Radiol; 2018 Oct; 28(10):4447-4454. PubMed ID: 29713769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients.
    Kalinowska-Lyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Bus K; Leszczynski P; Puszczewicz M; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Sep; 27(10):1624-1635. PubMed ID: 29950159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral horizontal gaze palsy in benign multiple sclerosis.
    Martinovic V; Nikolic I; Mesaros S; Drulovic J
    Acta Neurol Belg; 2020 Apr; 120(2):473-474. PubMed ID: 30560418
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.
    Kipfer S; Crook DW
    Mult Scler; 2014 May; 20(6):754-5. PubMed ID: 24402040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
    Frohman EM; Dwyer MG; Frohman T; Cox JL; Salter A; Greenberg BM; Hussein S; Conger A; Calabresi P; Balcer LJ; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):96-105. PubMed ID: 19439327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis.
    Nakamura M; Itani K; Miyake K; Kunieda T; Kaneko S; Kusaka H
    Intern Med; 2017; 56(2):211-214. PubMed ID: 28090055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The retinal ganglion cell layer predicts normal-appearing white matter tract integrity in multiple sclerosis: A combined diffusion tensor imaging and optical coherence tomography approach.
    Alves C; Batista S; d'Almeida OC; Sousa L; Cunha L; Bernardes R; Castelo-Branco M
    Hum Brain Mapp; 2018 Apr; 39(4):1712-1720. PubMed ID: 29334156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional connectivity impairment of postcentral gyrus in relapsing-remitting multiple sclerosis with somatosensory disorder.
    Fu J; Chen X; Gu Y; Xie M; Zheng Q; Wang J; Zeng C; Li Y
    Eur J Radiol; 2019 Sep; 118():200-206. PubMed ID: 31439243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies.
    Havrdova E; Giovannoni G; Gold R; Fox RJ; Kappos L; Phillips JT; Okwuokenye M; Marantz JL
    Eur J Neurol; 2017 May; 24(5):726-733. PubMed ID: 28328179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and radiological control of highly active relapsing-remitting multiple sclerosis with first-line natalizumab.
    Meca-Lallana JE; Carreón-Guarnizo E; Hernández-Clares R; García-Molina E; Díaz-Pérez J; Leon-Hernández A; Zamarro-Parra J; Martín-Fernández JJ
    Neurodegener Dis Manag; 2017 Jun; 7(3):175-181. PubMed ID: 28592169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tracking successive Wallerian degenerations in a relapsing-remitting multiple sclerosis patient.
    Hannoun S; Durand-Dubief F; Roch JA; Sappey-Marinier D; Cotton F
    J Neuroradiol; 2016 Oct; 43(5):359-61. PubMed ID: 27502574
    [No Abstract]   [Full Text] [Related]  

  • 34. Retinal imaging and axonal degeneration in later onset multiple sclerosis.
    Huhn K; Lämmer R; Zimmermann H; Lämmer A; Waschbisch A; Utz K; Gieß RM; Paul F; Linker RA; Lee DH
    J Neurol Sci; 2016 Nov; 370():1-6. PubMed ID: 27772735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.
    Castro SM; Damasceno A; Damasceno BP; Vasconcellos JP; Reis F; Iyeyasu JN; Carvalho KM
    Arq Neuropsiquiatr; 2013 Jul; 71(7):437-41. PubMed ID: 23857611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
    Sorensen PS; Sellebjerg F; Hartung HP; Montalban X; Comi G; Tintoré M
    Brain; 2020 Sep; 143(9):2637-2652. PubMed ID: 32710096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical relapses in multiple sclerosis.
    Puthenparampil M; Poggiali D; Causin F; Rolma G; Rinaldi F; Perini P; Gallo P
    Mult Scler; 2016 Aug; 22(9):1184-91. PubMed ID: 25791367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of peripheral III nerve in multiple sclerosis patient: Report of a new case and discussion of the underlying mechanism.
    Shor N; Amador MD; Dormont D; Lubetzki C; Bertrand A
    Mult Scler; 2017 Apr; 23(5):748-750. PubMed ID: 28185472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Problems in diagnosing cranial base meningioma in patients with multiple sclerosis.
    Mitosek-Szewczyk K; Stelmasiak Z
    Neurol Sci; 2003 Nov; 24(4):296-8. PubMed ID: 14658055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.
    Chiang GC; Pinto S; Comunale JP; Gauthier SA
    J Neuroimaging; 2016 May; 26(3):289-95. PubMed ID: 26458494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.